Cosopt and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Cosopt (dorzolamide hydrochloride; timolol maleate), especially for people who are female, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Cosopt. It is created by eHealthMe based on reports of 8,872 people who have side effects when taking Cosopt from the FDA, and is updated regularly.

What is Cosopt?

Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 9,029 Cosopt users. Check the latest studies of Cosopt.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,637 drugs and 2,517 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

On Jul, 18, 2026

8,872 people reported to have side effects when taking Cosopt.
Among them, 29 people (0.33%) have Urinary incontinence.

Could Cosopt cause Urinary incontinence?

Among these 29 people:

What is the gender of people who have Urinary incontinence when taking Cosopt? *

female: 82.76 %
male: 17.24 %

What is the age of people who have Urinary incontinence when taking Cosopt? *

What are other drugs people take besides Cosopt? *

What are other side effects people have besides Urinary incontinence? *

Fatigue (feeling of tiredness): 19 people, 65.52%
Urinary Tract Infection: 18 people, 62.07%
Pain: 17 people, 58.62%
Stress And Anxiety: 16 people, 55.17%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 55.17%
Osteopenia (a condition where bone mineral density is lower than normal): 16 people, 55.17%
Constipation: 16 people, 55.17%
Spinal Osteoarthritis (joint cartilage loss in spine): 16 people, 55.17%
Fall: 15 people, 51.72%
Weakness: 15 people, 51.72%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 14 people, 48.28%
Fever: 5 people, 17.24%
Anaemia (lack of blood): 4 people, 13.79%
Osteoporosis (bones weak and more likely to break): 4 people, 13.79%
Indigestion: 4 people, 13.79%
Breast Cancer Metastatic: 3 people, 10.34%
High Blood Pressure: 3 people, 10.34%
Agitation (state of anxiety or nervous excitement): 2 people, 6.90%
High Blood Cholesterol: 2 people, 6.90%
Depression: 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cosopt and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cosopt:

Cosopt (9,029 reports)

Urinary incontinence treatments and more:

Urinary incontinence (50,139 reports)

How severe was Urinary incontinence and when was it recovered:

Urinary incontinence in Cosopt

Expand to all the drugs that have ingredients of dorzolamide hydrochloride; timolol maleate:

Urinary incontinence and drugs with ingredients of dorzolamide hydrochloride; timolol maleate (36 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cosopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Urinary incontinence (1,637 drugs)

Browse all the conditions that are associated with Urinary incontinence:

Urinary incontinence (2,517 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dorzolamide hydrochloride; timolol maleate (the active ingredients of Cosopt) and Cosopt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.